Core MD
The BioMed Alliance is a partner in the CORE -MD project, a European project funded under Horizon 2020 that contributes to evidence-based decision making for medical devices.
The project, which was launched in April 2021, ran until March 2024 and aimed at translating expert knowledge into advice for regulatory guidance and building expertise and Regulatory Science in the clinical community. It reviewed methodologies for the clinical evaluation of high-risk medical devices and recommended new designs to set an appropriate balance between innovation, safety, and clinical effectiveness.
BioMed Alliance was co-leading work package 4 “Network and Community Building” and thus played an important role in the dissemination of the results, while also ensuring input from its members was included in different parts of the project.
The consortium was led by ESC and EFFORT and composed of a mix of medical societies, patient organisations, national regulatory agencies, academic institutions, notified bodies and other health stakeholders.
Work packages:
- WP5 Project management
- WP1 Understanding methods used to generate clinical evidence for high-risk medical devices
- WP2 Strengthening evidence for high-risk medical devices: New methods for generating clinical evidence.
- WP3 Extracting maximal value from medical device registries and real-world evidence.
- WP4 Networking and community building
For more information and results see the CORE-MD website.
‘This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965246.’